1. Gender Differences in Arrhythmias: Focused on Atrial Fibrillation
- Author
-
Xiao-Ting Tian, Ying-Jia Xu, and Yi-Qing Yang
- Subjects
Male ,0301 basic medicine ,medicine.medical_specialty ,Population ,Action Potentials ,Pharmaceutical Science ,Comorbidity ,030204 cardiovascular system & hematology ,Risk Assessment ,law.invention ,03 medical and health sciences ,Sex Factors ,0302 clinical medicine ,Randomized controlled trial ,Heart Conduction System ,Heart Rate ,Risk Factors ,law ,Atrial Fibrillation ,Genetics ,medicine ,Humans ,Sinus rhythm ,Healthcare Disparities ,Intensive care medicine ,education ,Stroke ,Genetics (clinical) ,Aged ,Aged, 80 and over ,education.field_of_study ,business.industry ,Age Factors ,Atrial fibrillation ,Health Status Disparities ,Middle Aged ,Prognosis ,medicine.disease ,030104 developmental biology ,Heart failure ,Molecular Medicine ,Female ,Treatment decision making ,Cardiology and Cardiovascular Medicine ,business ,Complication - Abstract
There are significant differences in clinical presentation and treatment of atrial fibrillation (AF) between women and men. The primary goal of AF management is to restore sinus rhythm and to prevent various complications, including stroke and heart failure. In many areas of AF, such as prevalence, clinical manifestations, morbidity, risk factors, pathophysiology, treatment strategies, and complications, gender-specific variability is observed and needs to be further addressed by large-scale population researches or randomized clinical trials, which help to promote the customization of AF treatment programs, hence to maximize the success rate of AF therapy in both sexes. This review highlights our current understanding of these gender differences in AF and how these differences affect treatment decisions on AF.
- Published
- 2019